CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced presentations at two upcoming investment conferences. The Verastem presentation details are as follows:
2012 RBC Capital Markets’ Global Healthcare Conference on Tuesday, February 28, 2012 at 4:35 p.m. (ET) at the New York Palace Hotel in New York City.
2012 RBC Capital Markets’ Global Healthcare Conference on Tuesday, February 28, 2012 at 4:35 p.m. (ET) at the New York Palace Hotel in New York City.
